.
MergerLinks Header Logo

New Deal


Announced

Evolent Health to acquire IPG from TPG Growth for $462m.

Financials

Edit Data
Transaction Value£437m
Consideration TypeContingent Deferred Consideration, Cash
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Private

Private Equity

Single Bidder

Pending

Majority

Acquisition

United States

FinTech

cost management

Friendly

Domestic

Synopsis

Edit

Evolent Health, a health management services organization that integrates the technology, tools and on-the-ground resources, agreed to acquire IPG, a technology and services company providing surgical management solutions for musculoskeletal conditions, from TPG Growth, a private equity firm, for $462m. "Today's announcement represents an important step in Evolent's journey to become a national leader in value-based specialty care solutions. The acquisition of IPG will expand Evolent's specialty portfolio, add new customers, and increase our commercial insurance revenue mix. IPG is a leader in surgical cost management solutions with a focus on musculoskeletal cost and quality and adds unique clinical value and an enhanced financial profile to support our mission for our patients, providers, payers and shareholders," Seth Blackley, Evolent Health Chief Executive Officer and Co-Founder.

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US